logo-loader
OTCQB:TOMDF

Todos Medical Ltd.

Receive alerts
Market:
OTCQB
Price
0.00000100 USD
Day Change
-
Market Cap:
$1.41 k
52 weeks high
0.0040
52 weeks low
0.00000100

In brief

Todos Medical Ltd, founded in Rehovot, Israel with offices in New York City, engineers life-saving diagnostic solutions for the early detection of a variety of cancers. In 2021, Todos completed the acquisition of US-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab currently performing PCR COVID testing and Provista's proprietary commercial-stage Videssa breast cancer blood test. The company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer screening technology using peripheral blood analysis that deploys deep examination into cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos' two internally-developed cancer-screening tests, TMB-1 and TMB-2, have received a CE mark in Europe. Todos is focused on the commercialization of Videssa and will bring the TBIA tests to market thereafter.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Emerging companies to connect with investors via Proactive One2One Investor Forum on August 25

Shareholders and others will have the opportunity to engage with top management from Biocept, Starton Therapeutics, Todos Medical, and Gevo

on 24/8/20